Kintara Therapeutics, Inc. (KTRA)

NASDAQ: KTRA · IEX Real-Time Price · USD

0.252

-0.022 (-8.06%)

At close: Jul 19, 2024, 4:00 PM

0.247

-0.006 (-2.22%)

Pre-market: Jul 22, 2024, 7:31 AM EDT

Kintara Therapeutics Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	2018 - 2010
Selling, General & Admin	4.78	5.49	7.51	9.76	4.51	4.74	Upgrade
Research & Development	4.64	9.31	15.17	11.82	3.63	3.66	Upgrade
Other Operating Expenses	0	0	0	16.59	1.05	0	Upgrade
Operating Expenses	9.42	14.8	22.68	38.17	9.2	8.4	Upgrade
Operating Income	-9.42	-14.8	-22.68	-38.17	-9.2	-8.4	Upgrade
Interest Expense / Income	-0.09	-0.14	-0.01	0.03	-0.08	0	Upgrade
Other Expense / Income	0.01	-0.01	-0.01	0.11	0	-0.35	Upgrade
Pretax Income	-9.33	-14.65	-22.66	-38.3	-9.13	-8.05	Upgrade
Net Income	-9.33	-14.65	-22.66	-38.3	-9.13	-8.05	Upgrade
Preferred Dividends	0.18	0.37	2.47	3.21	0.02	0.08	Upgrade
Net Income Common	-9.51	-15.02	-25.13	-41.5	-9.14	-8.13	Upgrade
Shares Outstanding (Basic)	45	2	1	1	0	0	Upgrade
Shares Outstanding (Diluted)	45	2	1	1	0	0	Upgrade
Shares Change	2550.92%	66.32%	88.13%	147.86%	305.64%	23.42%	Upgrade
EPS (Basic)	-4.07	-9.27	-25.80	-80.00	-43.50	-158.00	Upgrade
EPS (Diluted)	-4.07	-9.27	-25.80	-80.00	-43.50	-158.00	Upgrade
Free Cash Flow	-7.26	-12.1	-20.39	-18.87	-7.93	-6.33	Upgrade
Free Cash Flow Per Share	-0.16	-7.47	-20.94	-36.44	-37.95	-122.88	Upgrade
EBITDA	-9.37	-14.73	-22.62	-38.24	-9.19	-8.03	Upgrade
Depreciation & Amortization	0.05	0.06	0.06	0.03	0.01	0.02	Upgrade
EBIT	-9.42	-14.79	-22.68	-38.27	-9.2	-8.05	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).